Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class ITerminatedD-1150-2014

Drug recall · March 12, 2014

Super-DMZ Rx 2.0 Capsules recall

Why: Marketed without an Approved NDA/ANDA; product contains the steroid ingredient 2, 17a-dimethyl-17b-hydroxy-5a-androst-1-en-3-one, making it an unapproved new drug

Class I: a reasonable chance the product could cause serious harm or death.

The recall

Product

Super-DMZ Rx 2.0 Capsules, 60 count bottles, Dietary Supplement, Lean muscle mass, hardness and strength, Manufactured for Blackstone Labs Boca Raton, FL 33433.

Lots / codes

lot numbers: 1) M55Q (A) Exp 04/2016, 2) M55Q (2) Exp 05/16, 3)E07Q Exp unknown

Quantity
11,200 bottles (60 capsules per bottle) (quantities for E07Q unknown)
Company
Mira Health Products Ltd., Farmingdale, NY
Distribution
Nationwide
Initiated
July 22, 2013 · Voluntary: Firm initiated
Classified
March 5, 2014
Reported
March 12, 2014
Ended
September 15, 2014
How notified
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.